Knowledge of the role of IL-1β in mood disorders has been established through several means including epidemiological data [47], studies showing the modification of IL-1β expression following treatment of mood disorders [48], and the behavioral alterations documented following administration of IL-1β in pre-clinical studies [49]. This evidence concerns the gene IL1B and mood disorder.